Intra-articular targeted delivery of nanomaterials for the treatment of osteoarthritis: focusing on cell signaling pathway mechanisms
Nanomaterials for osteoarthritis treatment are evolving from passive drug carriers to intelligently responsive, targeted multifunctional systems capable of personalized, proactive, and regenerative therapy, overcoming current limitations in toxicity and delivery precision.
Authors
- Xin Li (ORCID: https://orcid.org/0000-0003-0003-8554)
- Bo Gu (ORCID: https://orcid.org/0000-0003-3869-1292)
- Yuanqiang Ma
- Shuya Wang (ORCID: https://orcid.org/0000-0002-1031-8907)
- Jiantao Zhang (ORCID: https://orcid.org/0000-0002-2875-9743)
- Jingjing Qi (ORCID: https://orcid.org/0000-0002-6426-2136)
- Tianwen Ma (ORCID: https://orcid.org/0000-0003-3809-1131)
Institutions
- Harbin Medical University (CN)
- Chungbuk National University (KR)
- Northeast Agricultural University (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Delivery
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1080/17425247.2025.2600610
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00